iRhythm Technologies Investor Presentation May 2023

iRhythm Technologies investor presentation from May 2023 highlighting the company's position in the ambulatory cardiac monitoring market with ~25% penetration, serving 6+ million patients globally across 66 countries. The presentation covers clinical results, market opportunities, business strategy, and non-GAAP financial measures supporting 30%+ five-year revenue growth.